Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden

[1]  Sarah E. Wilson,et al.  Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study , 2022, BMJ.

[2]  V. Pitzer,et al.  Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study , 2022, BMJ.

[3]  A. Copas,et al.  Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study , 2022, The Lancet Healthy Longevity.

[4]  R. Arbel,et al.  Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years , 2022, Nature Medicine.

[5]  M. Hernán,et al.  Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting , 2022, The New England journal of medicine.

[6]  Michael I. Mandel,et al.  Protection by a Fourth Dose of BNT162b2 against Omicron in Israel , 2022, The New England journal of medicine.

[7]  J. Fernández-Niño,et al.  Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort , 2022, The Lancet Healthy Longevity.

[8]  A. Nordström,et al.  Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden , 2022, The Lancet.

[9]  M. Kivipelto,et al.  Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities , 2021, Journal of the American Medical Directors Association.

[10]  A. Ahlbom,et al.  Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: A population-based study , 2021, The Lancet regional health. Europe.

[11]  A. Nordström,et al.  Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study , 2021, European Journal of Epidemiology.

[12]  K. Michaëlsson,et al.  Registers of the Swedish total population and their use in medical research , 2016, European Journal of Epidemiology.

[13]  P. Höglund,et al.  Senior Alert: A Quality Registry to Support a Standardized, Structured, and Systematic Preventive Care Process for Older Adults , 2015, Quality management in health care.

[14]  B. Vellas,et al.  Validation of the Mini Nutritional Assessment short-form (MNA®-SF): A practical tool for identification of nutritional status , 2009, The journal of nutrition, health & aging.

[15]  C. Álvarez-Nieto,et al.  Risk assessment scales for pressure ulcer prevention: a systematic review. , 2006, Journal of advanced nursing.